אימוראן טבליות 25 מג ישראל - עברית - Ministry of Health

אימוראן טבליות 25 מג

padagis israel agencies ltd, israel - azathioprine - טבליות מצופות פילם - azathioprine 25 mg - azathioprine - azathioprine - immunosuppressive agent used in transplantation surgery for suppression of graft rejection. for special cases of rheumatoid arthritis- not responsive to other agents- and only by rheumatology experts in hospitals or rheumatic clinics.

אינוטיול ישראל - עברית - Ministry of Health

אינוטיול

padagis israel agencies ltd, israel - benzoin siam; hamamelis; ichthammol; titanium dioxide; zinc oxide - משחה - ichthammol 1.474 g / 100 g; zinc oxide 14.763 g / 100 g; hamamelis 0.984 g / 100 g; benzoin siam 0.1 g / 100 g; titanium dioxide 5.905 g / 100 g - other anti-acne preparations for systemic use - local treatment of eczema, feet ulcers, mild burns and skin irritations.

אינוטיול ישראל - עברית - Ministry of Health

אינוטיול

perrigo israel agencies ltd, israel - benzoin siam; hamamelis; ichthammol; titanium dioxide; zinc oxide - משחה - ichthammol 1.474 g / 100 g; zinc oxide 14.763 g / 100 g; hamamelis 0.984 g / 100 g; benzoin siam 0.1 g / 100 g; titanium dioxide 5.905 g / 100 g

טרוסמוליט 20 מג ישראל - עברית - Ministry of Health

טרוסמוליט 20 מג

cts chemical industries ltd, israel - trospium chloride - טבליות מצופות פילם - trospium chloride 20 mg - trospium

פמוטידין טבע  20 מג ישראל - עברית - Ministry of Health

פמוטידין טבע 20 מג

teva pharmaceutical industries ltd, israel - famotidine - טבליה - famotidine 20 mg - famotidine - famotidine - treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract.

קונטרולוק 20 מג ישראל - עברית - Ministry of Health

קונטרולוק 20 מג

takeda israel ltd - pantoprazole - טבליה - pantoprazole 20 mg - pantoprazole - pantoprazole - treatment of reflux oesophagitis and associated symptoms (e.g. hearburn acid regurgitation pain on swallowing) . for long-term management and prevention of relapse in reflux oesophagitis. prevention of gastroduodenal ulcers induced by non-steroidal anti-inflammatory drugs (nsaids) in patients at risk with a need for continuous nsaids treatment.

ג'נוביה 25 מג ישראל - עברית - Ministry of Health

ג'נוביה 25 מג

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - טבליות מצופות פילם - sitagliptin as monohydrate phosphate 25 mg - sitagliptin - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

אלפא  די 3 0.25 מקג ישראל - עברית - Ministry of Health

אלפא די 3 0.25 מקג

truemed ltd, israel - alfacalcidol - קפסולות ג'לטין רכות - alfacalcidol 0.25 mcg - alfacalcidol - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.

רבולייד 25 מג ישראל - עברית - Ministry of Health

רבולייד 25 מג

novartis israel ltd - eltrombopag as olamine - טבליות מצופות פילם - eltrombopag as olamine 25 mg - eltrombopag - eltrombopag - for the treatment of previously treated patients with chronic idiopathic thrombocytopenic purpura (itp) to increase platelet count and reduce or prevent bleeding.

קרסטור   20 מג ישראל - עברית - Ministry of Health

קרסטור 20 מג

astrazeneca (israel) ltd - rosuvastatin as calcium - טבליות מצופות פילם - rosuvastatin as calcium 20 mg - rosuvastatin - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.